CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | Larson Betty D EVP, Chief HR Officer | Grant or award · Restricted Stock Unit | +7,954 | 7,954 | ||
| 2026-05-05 | Larson Betty D EVP, Chief HR Officer | Grant or award · Stock Option (Right to Buy) | +23,283 | 23,283 | ||
| 2026-05-05 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award · Restricted Stock Unit | +11,931 | 11,931 | ||
| 2026-05-05 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award · Stock Option (Right to Buy) | +34,924 | 34,924 | ||
| 2026-05-05 | Davis Robert M Chairman, CEO & President | Grant or award · Restricted Stock Unit | +47,724 | 47,724 | ||
| 2026-05-05 | Davis Robert M Chairman, CEO & President | Grant or award · Stock Option (Right to Buy) | +139,697 | 139,697 | ||
| 2026-05-05 | Foard Brian EVP, Specialty, Pharma, & ID | Grant or award · Restricted Stock Unit | +10,605 | 10,605 | ||
| 2026-05-05 | Foard Brian EVP, Specialty, Pharma, & ID | Grant or award · Restricted Stock Unit | +35,351 | 35,351 | ||
| 2026-05-05 | Foard Brian EVP, Specialty, Pharma, & ID | Grant or award · Stock Option (Right to Buy) | +31,044 | 31,044 | ||
| 2026-05-05 | Maraldo David R. EVP & Pres. MMD | Grant or award · Restricted Stock Unit | +7,424 | 7,424 | ||
| 2026-05-05 | Maraldo David R. EVP & Pres. MMD | Grant or award · Stock Option (Right to Buy) | +21,731 | 21,731 | ||
| 2026-05-05 | Oosthuizen Johannes Jacobus EVP, Oncology & Int?l | Grant or award · Restricted Stock Unit | +10,605 | 10,605 | ||
| 2026-05-05 | Oosthuizen Johannes Jacobus EVP, Oncology & Int?l | Grant or award · Stock Option (Right to Buy) | +31,044 | 31,044 | ||
| 2026-05-05 | Smart Dalton E. III SVP Fin. - Global Controller | Grant or award · Restricted Stock Unit | +2,298 | 2,298 | ||
| 2026-05-05 | Smart Dalton E. III SVP Fin. - Global Controller | Grant or award · Stock Option (Right to Buy) | +5,045 | 5,045 | ||
| 2026-05-05 | Guindo Chirfi EVP, Access, Policy & Comms | Grant or award · Restricted Stock Unit | +6,628 | 6,628 | ||
| 2026-05-05 | Guindo Chirfi EVP, Access, Policy & Comms | Grant or award · Stock Option (Right to Buy) | +19,402 | 19,402 | ||
| 2026-05-02 | Smart Dalton E. III SVP Fin. - Global Controller | Option exercise | +383 | $112.16 | $43K | 9,520.32 |
| 2026-05-02 | Smart Dalton E. III SVP Fin. - Global Controller | Shares withheld for taxes | −132 | $112.16 | $15K | 9,388.32 |
| 2026-05-02 | Smart Dalton E. III SVP Fin. - Global Controller | Option exercise · Restricted Stock Unit | −383 | 0 |
Page 4 of 19 · 376 trades